Investor's Calendar
Mon | Tue | Wed | Thu | Fri | Sat | Sun |
---|---|---|---|---|---|---|
29
|
30
|
31
|
1
|
2
|
3
|
4
|
|
|
|
|
|
|
|
5
|
6
|
7
|
8
|
9
|
10
|
11
|
|
|
|
|
|
|
|
12
|
13
|
14
|
15
|
16
|
17
|
18
|
|
|
|
|
|
|
|
19
|
20
|
21
|
22
|
23
|
24
|
25
|
|
|
|
|
|
|
|
26
|
27
|
28
|
29
|
1
|
2
|
3
|
|
|
|
|
|
|
Last News
ROVI closes the quarter with operating revenue of 151.2 million euros
4 min
08 May, 2024
Agreement to manufacture pre-filled syringes for a global pharmaceutical company
3 min
25 Apr, 2024
Risperidone ISM® is a prolonged-release injectable antipsychotic developed and patented by ROVI for the...
4 min
02 Apr, 2024
Public statements sent to CNMV
ESG
Discover what ROVI is doing to become a more sustainable company
CORPORATE GOVERNANCE
Find out more about ROVI’s main governing bodies